Our May 22, 2025 guidance regarding the use of the estimated allowed amount was an important first step towards requiring the disclosure of the actual prices of items and services, not estimates, and ensuring pricing information is standardized and easily comparable across hospitals and health plans
: Power System L-Carnitine Liquid 3600 mg ,
Products marketed as research chemicals occupy a gray area with less clear enforcement but still face regulatory risk
First, expanded access often called "compassionate use" is normally reserved for immediately life-threatening conditions with no remaining treatment options
GLP-1 receptor agonists were first developed in the early 2000s Weight loss was initially observed as a secondary effect, not the primary goal For nearly two decades, these medications were studied primarily through the lens of blood sugar regulation and insulin sensitivity
The GLP-1 market changes fast, new drugs, shifting payer rules, evolving science